GelStat Corp
GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and G… Read more
GelStat Corp (GSAC) - Total Liabilities
Latest total liabilities as of June 2025: $1.52 Million USD
Based on the latest financial reports, GelStat Corp (GSAC) has total liabilities worth $1.52 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
GelStat Corp - Total Liabilities Trend (1996–2024)
This chart illustrates how GelStat Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
GelStat Corp Competitors by Total Liabilities
The table below lists competitors of GelStat Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shyam Telecom Limited
NSE:SHYAMTEL
|
India | ₹280.20 Million |
|
2G ENERGY
BE:2GB
|
Germany | €103.46 Million |
|
SHINKO EL IND
MU:SKS
|
Germany | €128.77 Billion |
|
CONSOL ENERGY - Dusseldorf Stock Exchang
DU:CGD
|
Germany | €4.28 Billion |
|
EV Technology Group Ltd.
PINK:EVTGF
|
USA | $6.40 Million |
|
KAJIMA
MU:KAJ
|
Germany | €1.91 Trillion |
|
IMPERIAL TOBACCO
MU:ITB
|
Germany | €23.46 Billion |
Liability Composition Analysis (1996–2024)
This chart breaks down GelStat Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.30 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 4.76 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how GelStat Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for GelStat Corp (1996–2024)
The table below shows the annual total liabilities of GelStat Corp from 1996 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $1.22 Million | +26.37% |
| 2023-12-31 | $964.37K | +33.18% |
| 2022-12-31 | $724.09K | +41.68% |
| 2021-12-31 | $511.06K | +48.59% |
| 2020-12-31 | $343.94K | +7.48% |
| 2019-12-31 | $320.00K | +1486.36% |
| 2018-12-31 | $20.17K | -98.53% |
| 2014-12-31 | $1.37 Million | +554.92% |
| 2013-12-31 | $209.74K | -2.70% |
| 2012-12-31 | $215.56K | -79.84% |
| 2011-12-31 | $1.07 Million | -3.90% |
| 2004-12-31 | $1.11 Million | +275.09% |
| 2003-12-31 | $296.57K | +321.21% |
| 2002-12-31 | $70.41K | -86.25% |
| 2001-12-31 | $512.01K | +202.98% |
| 2000-12-31 | $168.99K | -46.14% |
| 1999-12-31 | $313.79K | -57.15% |
| 1998-12-31 | $732.37K | -41.67% |
| 1997-12-31 | $1.26 Million | 0.00% |
| 1996-12-31 | $1.26 Million | -- |